Wednesday, Sep 23, 2026 Updated Sep 23, 01:30 UTC

NewSpace RFP

We track the space industry: contracts, hiring, launches, patents, funding, suppliers and company activity.

SupportNewSpace RFP
NASA Primary source

Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications

Risks of Decompression Sickness and Venous Thromboembolism during Spaceflight and Patent Foramen Ovale Implications

Image: NASA

NASA’s Office of the Chief Health and Medical Officer formed a working group in August 2026 to review the most recent data related to extravehicular activity (EVA) prebreathe testing and decompression sickness (DCS) events, venous thromboembolism (VTE) in-flight occurrences, and patent foramen ovale (PFO) implication as they relate to NASA’s Artemis (lunar and beyond) missions. The recommendations from this working group are built upon and integrate the outcomes of previous working groups hosted by OCHMO.

Summary by NASA, the primary source

Read the release at NASA